Showing results (2221-2230 of 4,522) with videos related to

Sort By:
Pageof 453
Advances in Therapy|September 17, 2020
A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver DiseaseIgor V Maev, Alexey A Samsonov, Leonid B Lazebnik, et al.
Advances in Therapy|July 15, 2021
Benefit-Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to HarmLeslie Citrome, Margarita Sánchez Del Rio, Yan Dong, et al.
Advances in Therapy|May 28, 2021
Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin RecommendationsErica B Friedman, Richard A Scolyer, Gabrielle J Williams, et al.
Advances in Therapy|July 12, 2021
Efficacy and Safety of PreserFlo® MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective StudyLuciano Quaranta, Eleonora Micheletti, Roberto Carassa, et al.
Advances in Therapy|May 27, 2021
Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and SurvivalAgnieszka Maj-Hes, Tibor Szarvas, Sabina Sevcenco, et al.
Advances in Therapy|November 27, 2020
Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice ExperimentAtaru Igarashi, Brian Bekker Hansen, Jakob Langer, et al.
Advances in Therapy|November 27, 2020
A Patient Charter for Chronic Obstructive Pulmonary DiseaseJohn R Hurst, Tonya Winders, Heinrich Worth, et al.
Advances in Therapy|November 27, 2020
Annual Cost Burden by Level of Relapse Severity in Patients with Multiple SclerosisJacqueline Nicholas, Huanxue Zhou, Chinmay Deshpande
Advances in Therapy|June 11, 2021
The Number of Pills, Rather Than the Type of Renin-Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional StudyRiccardo Sarzani, Federico Giulietti, Andrea Filipponi, et al.
Advances in Therapy|October 4, 2020
24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL StudyDavid A Lipson, Ruby Birk, Noushin Brealey, et al.
Pageof 453